Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADPT | BMY | AMGN | GILD | VRTX |
| Company | Adaptive Biotechnologies Corp | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.50 | 49.16 | 272.14 | 67.09 | 404.00 |
| High | 2.73 | 49.47 | 274.35 | 67.68 | 406.86 |
| Low | 2.45 | 48.96 | 271.05 | 67.06 | 403.47 |
| Last | 2.65 | 49.22 | 274.01 | 67.29 | 405.00 |
| Change | +0.14 | +0.08 | +2.10 | +0.34 | +5.08 |
| % Change | +5.58% | +0.16% | +0.77% | +0.51% | +1.27% |
| Volume | 732,584 | 3,800,375 | 1,056,809 | 2,250,935 | 385,589 |
| 20-Day Average Volume | 2,204,026 | 10,668,141 | 2,137,906 | 6,178,187 | 941,773 |
| Previous Close | 2.51 | 49.14 | 271.91 | 66.95 | 399.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.76 | 50.57 | 272.01 | 69.35 | 404.13 |
| 20-Day Raw Stochastic | 33.65% | 24.64% | 47.82% | 16.19% | 43.00% |
| 20-Day Relative Strength | 42.39% | 43.30% | 49.15% | 33.72% | 47.23% |
| Weighted Alpha | -63.30 | -25.08 | +11.72 | -20.60 | +17.42 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 8% Buy | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.18% since 04/16/24 | +2.17% since 04/16/24 | +3.15% since 04/16/24 | -0.18% since 04/16/24 | +2.52% since 04/16/24 |
| Low | 2.28 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 2.80 on 04/17/24 | 49.56 on 04/22/24 | 274.08 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -18.67% since 03/22/24 | -5.05% since 03/22/24 | -0.78% since 03/22/24 | -7.46% since 03/22/24 | -2.78% since 03/22/24 |
| Low | 2.28 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 3.34 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -39.70% since 01/23/24 | -1.63% since 01/23/24 | -11.58% since 01/23/24 | -15.46% since 01/23/24 | -8.10% since 01/23/24 |
| Low | 2.28 on 04/19/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 4.49 on 01/24/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -36.96% since 10/23/23 | -11.96% since 10/23/23 | +0.35% since 10/23/23 | -13.37% since 10/23/23 | +9.91% since 10/23/23 |
| Low | 2.28 on 04/19/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 5.49 on 12/28/23 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 364,181 | 99,594,944 | 145,845,984 | 83,357,904 | 103,362,928 |
| Shares Outstanding, K | 145,092 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 170,280,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -225,250,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 45,780,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -69,440,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.25 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.30 on 02/14/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/07/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 9.93 | 29.34 |